To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Johnson & Johnson raised its full-year sales outlook as it posted gains in both its prescription-drug and medical-device businesses in the latest quarter https://t.co/S7u50FSGnq ...

US stock markets are experiencing a renewed wave of volatility this Tuesday, October 14, 2025, as escalating trade tensions between the United States and China overshadow a robust start to the third-quarter earnings season. After a significant rebound on Monday, driven by a temporary easing of trade rhetoric, markets opened lower today, reflecting investor apprehension over Beijing's retaliatory measures. By midday, a mixed picture emerged, with major indexes attempting to pare some of their initial losses, ...

By Patrick Wingrove (Reuters) -Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years as it sharpens focus on higher-growth healthcare segments. J&J also outlined expectations for faster growth into 2026, driven by new drug launches and a strengthened medical devices portfolio, and raised its 2025 sales forecast after reporting quarterly earnings that toppe ...

Stocks slumped in morning trading on Wall Street Tuesday as trade tensions escalate again with China.The S&P 500 fell one per cent. The Dow Jones Industrial Average slipped 383 points, or 0.8 per cent, as of 9:57 a.m. Eastern time. The Nasdaq composite shed 1.5 per cent.The slide marks another sharp twist for markets over the last few days. Wall Street tumbled on Friday for its worst day since April and bounced back on Monday for its best day since May. The swings were prompted by shifting trade sentiment ...

Johnson & Johnson (J&J), the global healthcare industry bellwether, announced on Tuesday its plan to separate its orthopaedics division from the main company within the next 18 to 24 months. This major organisational shift was revealed as the pharmaceutical and medical technology firm reported third quarter results that surpassed Wall Street expectations.The orthopaedics business, which focuses on products such as hip and knee replacements and spinal equipment, is currently known as DePuy Synthes and genera ...

The decline adds to recent volatility, following Wall Street’s worst day since April last Friday and a rebound on Monday, which was the best day since May. Analysts said the swings reflected shifting sentiment over US-China trade relations.The latest downturn came after China’s Commerce Ministry barred Chinese companies from dealing with five subsidiaries of South Korean shipbuilder Hanwha Ocean, a move seen as countering President Donald Trump’s efforts to rebuild US shipbuilding. European markets were als ...

Johnson & Johnson (JNJ) reported $23.99 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 6.8%. EPS of $2.80 for the same period compares to $2.42 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $23.75 billion, representing a surprise of +1.03%. The company delivered an EPS surprise of +1.08%, with the consensus EPS estimate being $2.77.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...

LewisTsePuiLung/iStock Editorial via Getty Images Listen below or on the go on Apple Podcasts and Spotify J.P. Morgan, Goldman, Wells Fargo top estimates. (0:16) Oracle deploying 50,000 AMD chips. (1:41) Geopolitical arbitrage increasing as Americans seed golden visas. (2:14) This is an abridged transcript of the podcast: Our top story so far, big banks are kicking off earnings season with consensus-bearing results – as usual. Among the results for the heavy hitters: JPMorgan Chase (NYSE:JPM) nudged ...

Welcome to Yahoo Finance's flagship show, The Morning Brief. I'm Julie Hyman. Let's get to the three things you need to know today.First up, US stock futures falling as tensions escalate between the US and China. China retaliating against President Trump's threats by sanctioning the US units of a South Korean shipping giant that has spurred risk off sentiment across financial markets. Investors flocking to bonds while crypto assets are plunging.Plus, investors are also watching big bank earnings results fro ...